Gene · 64006
Papers4,423
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 4,423
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Experimental Models of SARS-COV-2 Infection in the Central Nervous System. | J Cent Nerv Syst Dis | 2022 | 35783991 | PubTator, text mining | PubMed |
| PHILM2Web: A high-throughput database of macromolecular host-pathogen interactions on the Web. | Database (Oxford) | 2022 | 35776535 | PubTator, text mining | PubMed |
| A Bioinformatics Approach to Investigate Structural and Non-Structural Proteins in Human Coronaviruses. | Front Genet | 2022 | 35774504 | PubTator, text mining | PubMed |
| Pervasive translation of circular RNAs driven by short IRES-like elements. | Nat Commun | 2022 | 35768398 | PubTator, text mining | PubMed |
| Natural selection plays a significant role in governing the codon usage bias in the novel SARS-CoV-2 variants of concern (VOC). | PeerJ | 2022 | 35765592 | PubTator, text mining | PubMed |
| Seroprevalence of neutralizing antibodies against adenovirus type 26 and 35 in healthy populations from Guangdong and Shandong provinces, China. | Virol Sin | 2022 | 35764207 | PubTator, text mining | PubMed |
| De Novo design of potential inhibitors against SARS-CoV-2 Mpro. | Comput Biol Med | 2022 | 35763931 | PubTator, text mining | PubMed |
| Production and immunogenicity of different prophylactic vaccines for hepatitis C virus (Review). | Exp Ther Med | 2022 | 35761816 | PubTator, text mining | PubMed |
| Identification of SARS-CoV-2 Variants of Concern Using Amplicon Next-Generation Sequencing. | Microbiol Spectr | 2022 | 35758686 | PubTator, text mining | PubMed |
| Insights Into the Biogenesis and Emerging Functions of Lipid Droplets From Unbiased Molecular Profiling Approaches. | Front Cell Dev Biol | 2022 | 35756995 | PubTator, text mining | PubMed |
| Non-neutralizing antibodies: Deleterious or propitious during SARS-CoV-2 infection? | Int Immunopharmacol | 2022 | 35753123 | PubTator, text mining | PubMed |
| MicroRNAs in the development of potential therapeutic targets against COVID-19: A narrative review. | J Infect Public Health | 2022 | 35751930 | PubTator, text mining | PubMed |
| The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19. | Inflamm Res | 2022 | 35751653 | PubTator, text mining | PubMed |
| Human Neutrophils Present Mild Activation by Zika Virus But Reduce the Infection of Susceptible Cells. | Front Immunol | 2022 | 35747137 | PubTator, text mining | PubMed |
| Azelnidipine Exhibits In Vitro and In Vivo Antiviral Effects against Flavivirus Infections by Targeting the Viral RdRp. | Viruses | 2022 | 35746699 | PubTator, text mining | PubMed |
| Single-Domain Antibodies as Therapeutics for Respiratory RNA Virus Infections. | Viruses | 2022 | 35746634 | PubTator, text mining | PubMed |
| Recombination between the Fostera MLV-like Strain and the Strain Belonging to Lineage 1 of Porcine Reproductive and Respiratory Syndrome Virus in Korea. | Viruses | 2022 | 35746625 | PubTator, text mining | PubMed |
| Nucleic Acid Vaccine Platform for DENGUE and ZIKA Flaviviruses. | Vaccines (Basel) | 2022 | 35746442 | PubTator, text mining | PubMed |
| Near-Infrared Spectroscopy as a Potential COVID-19 Early Detection Method: A Review and Future Perspective. | Sensors (Basel) | 2022 | 35746172 | PubTator, text mining | PubMed |
| Artemisia Extracts and Artemisinin-Based Antimalarials for COVID-19 Management: Could These Be Effective Antivirals for COVID-19 Treatment? | Molecules | 2022 | 35744958 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64006/papers?page=49